186 related articles for article (PubMed ID: 32377334)
1. The anti-neoplastic effect of doxycycline in osteosarcoma as a metalloproteinase (MMP) inhibitor: a systematic review.
Hadjimichael AC; Foukas AF; Savvidou OD; Mavrogenis AF; Psyrri AK; Papagelopoulos PJ
Clin Sarcoma Res; 2020; 10():7. PubMed ID: 32377334
[TBL] [Abstract][Full Text] [Related]
2. Doxycycline inhibits the progression of metastases in early-stage osteosarcoma by downregulating the expression of MMPs, VEGF and ezrin at primary sites.
Hadjimichael AC; Foukas AF; Papadimitriou E; Kaspiris A; Peristiani C; Chaniotakis I; Kotsari M; Pergaris A; Theocharis S; Sarantis P; Christopoulou M; Psyrri A; Mavrogenis AF; Savvidou OD; Papagelopoulos PJ; Armakolas A
Cancer Treat Res Commun; 2022; 32():100617. PubMed ID: 36027697
[TBL] [Abstract][Full Text] [Related]
3. An alternative therapy for idiopathic pulmonary fibrosis by doxycycline through matrix metalloproteinase inhibition.
Mishra A; Bhattacharya P; Paul S; Paul R; Swarnakar S
Lung India; 2011 Jul; 28(3):174-9. PubMed ID: 21886950
[TBL] [Abstract][Full Text] [Related]
4. Direct action by doxycycline against canine osteosarcoma cell proliferation and collagenase (MMP-1) activity in vitro.
Cakir Y; Hahn KA
In Vivo; 1999; 13(4):327-31. PubMed ID: 10586373
[TBL] [Abstract][Full Text] [Related]
5. Doxycycline down-regulates matrix metalloproteinase expression and inhibits NF-κB signaling in LPS-induced PC3 cells.
Ogut D; Reel B; Gonen Korkmaz C; Arun MZ; Cilaker Micili S; Ergur BU
Folia Histochem Cytobiol; 2016; 54(4):171-180. PubMed ID: 27966209
[TBL] [Abstract][Full Text] [Related]
6. Matrix metalloproteinases participate in osteosarcoma invasion.
Bjørnland K; Flatmark K; Pettersen S; Aaasen AO; Fodstad O; Maelandsmo GM
J Surg Res; 2005 Aug; 127(2):151-6. PubMed ID: 16083752
[TBL] [Abstract][Full Text] [Related]
7. Matrix metalloproteinase inhibitors.
Wojtowicz-Praga SM; Dickson RB; Hawkins MJ
Invest New Drugs; 1997; 15(1):61-75. PubMed ID: 9195290
[TBL] [Abstract][Full Text] [Related]
8. Matrix metalloproteinases, tissue inhibitor of matrix metalloproteinase-1, and laminin-5 gamma2 chain immunolocalization in gingival tissue of endotoxin-induced periodontitis in rats: effects of low-dose doxycycline and alendronate.
Buduneli E; Vardar-Sengül S; Buduneli N; Atilla G; Wahlgren J; Sorsa T
J Periodontol; 2007 Jan; 78(1):127-34. PubMed ID: 17199549
[TBL] [Abstract][Full Text] [Related]
9. Pathological and therapeutic aspects of matrix metalloproteinases: Implications in osteosarcoma.
Tang H; Tang Z; Jiang Y; Wei W; Lu J
Asia Pac J Clin Oncol; 2019 Aug; 15(4):218-224. PubMed ID: 31111666
[TBL] [Abstract][Full Text] [Related]
10. In vitro modulation of MMP-2 and MMP-9 in pediatric human sarcoma cell lines by cytokines, inducers and inhibitors.
Roomi MW; Kalinovsky T; Rath M; Niedzwiecki A
Int J Oncol; 2014 Jan; 44(1):27-34. PubMed ID: 24190483
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of proliferation and induction of apoptosis by doxycycline in cultured human osteosarcoma cells.
Fife RS; Rougraff BT; Proctor C; Sledge GW
J Lab Clin Med; 1997 Nov; 130(5):530-4. PubMed ID: 9390641
[TBL] [Abstract][Full Text] [Related]
12. Endothelial tubulogenesis within fibrin gels specifically requires the activity of membrane-type-matrix metalloproteinases (MT-MMPs).
Lafleur MA; Handsley MM; Knäuper V; Murphy G; Edwards DR
J Cell Sci; 2002 Sep; 115(Pt 17):3427-38. PubMed ID: 12154073
[TBL] [Abstract][Full Text] [Related]
13. Doxycycline suppresses cerebral matrix metalloproteinase-9 and angiogenesis induced by focal hyperstimulation of vascular endothelial growth factor in a mouse model.
Lee CZ; Xu B; Hashimoto T; McCulloch CE; Yang GY; Young WL
Stroke; 2004 Jul; 35(7):1715-9. PubMed ID: 15166398
[TBL] [Abstract][Full Text] [Related]
14. Neutrophil granulocyte derived MMP-9 is a VEGF independent functional component of the angiogenic switch in pancreatic ductal adenocarcinoma.
Bausch D; Pausch T; Krauss T; Hopt UT; Fernandez-del-Castillo C; Warshaw AL; Thayer SP; Keck T
Angiogenesis; 2011 Sep; 14(3):235-43. PubMed ID: 21442180
[TBL] [Abstract][Full Text] [Related]
15. Anti-invasion and anti-tumor growth effect of doxycycline treatment for human oral squamous-cell carcinoma--in vitro and in vivo studies.
Shen LC; Chen YK; Lin LM; Shaw SY
Oral Oncol; 2010 Mar; 46(3):178-84. PubMed ID: 20036604
[TBL] [Abstract][Full Text] [Related]
16. Comparison of doxycycline and minocycline in the inhibition of VEGF-induced smooth muscle cell migration.
Yao JS; Shen F; Young WL; Yang GY
Neurochem Int; 2007 Feb; 50(3):524-30. PubMed ID: 17145119
[TBL] [Abstract][Full Text] [Related]
17. Matrix Metalloproteinases, Tissue Inhibitor of Matrix Metalloproteinase-1, and Laminin-5 γ2 Chain Immunolocalization in Gingival Tissue of Endotoxin-Induced Periodontitis in Rats: Effects of Low-Dose Doxycycline and Alendronate.
Buduneli E; Vardar-Şengül S; Buduneli N; Atilla G; Wahlgren J; Sorsa T
J Periodontol; 2007 Jan; 78(1):127-134. PubMed ID: 29539192
[TBL] [Abstract][Full Text] [Related]
18. MMP inhibition in abdominal aortic aneurysms. Rationale for a prospective randomized clinical trial.
Thompson RW; Baxter BT
Ann N Y Acad Sci; 1999 Jun; 878():159-78. PubMed ID: 10415728
[TBL] [Abstract][Full Text] [Related]
19. Cross-talk between vascular endothelial growth factor and matrix metalloproteinases in the induction of neovascularization in vivo.
Ebrahem Q; Chaurasia SS; Vasanji A; Qi JH; Klenotic PA; Cutler A; Asosingh K; Erzurum S; Anand-Apte B
Am J Pathol; 2010 Jan; 176(1):496-503. PubMed ID: 19948826
[TBL] [Abstract][Full Text] [Related]
20. Mechanism of inhibition of matrix metalloproteinase-2 expression by doxycycline in human aortic smooth muscle cells.
Liu J; Xiong W; Baca-Regen L; Nagase H; Baxter BT
J Vasc Surg; 2003 Dec; 38(6):1376-83. PubMed ID: 14681644
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
